Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05885776 | Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research(PYTHON) | unknown | Phase 2 | 48 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 |
| Jun 2, 2023 |
| clinicaltrials |
| NCT05887154 | Non Surgical Treatment (Microwave Ablation) of Breast Cancer(MASTER) | unknown | N/A | 15 | University Medical Center GroningenOTHER | 0 | Jun 2, 2023 | clinicaltrials |
| NCT03567720 | Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC | unknown | Phase 2 | 65 | OncoSec Medical IncorporatedINDUSTRY | 2 | Jun 1, 2023 | clinicaltrials |
| NCT04500262 | Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes(COMPULSE) | unknown | N/A | 479 | NeoDynamics ABINDUSTRY | 1 | Jun 1, 2023 | clinicaltrials |
| NCT04510532 | Early Detection of CMP in Patients With Breast Cancer Using Cardiac Magnetic Resonance | unknown | — | 300 | RenJi HospitalOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT04265937 | ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies(SIGHT) | unknown | — | 5,000 | Fudan UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05689398 | Rehabilitation on Equal Terms - The ReMig Study | unknown | — | 140 | Lund UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05882019 | Evaluation of the Bexa™ Breast Examination (BBE) | unknown | N/A | 700 | Sure, Inc.INDUSTRY | 0 | May 31, 2023 | clinicaltrials |
| NCT05880927 | Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer | unknown | Phase 2 | 150 | Taizhou HospitalOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05878678 | Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position | unknown | Phase 2 | 200 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT05302778 | Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer(HERMIONE-10) | unknown | — | 200 | University of Milano BicoccaOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05872412 | Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer | unknown | Phase 2 | 82 | Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05876728 | Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer | unknown | — | 100 | Sohag UniversityOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05873036 | Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer Surgery | unknown | N/A | 74 | Superior UniversityOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT03383835 | Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer | unknown | N/A | 11 | Lauren NyeOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05870813 | CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer(CLEAR-B) | unknown | — | 3,000 | Institut fuer FrauengesundheitOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05868252 | Molecular Analysis of the Sloane Project | unknown | — | 1,500 | King's College LondonOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT05763992 | Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial(BREAKFAST-2) | unknown | Phase 2 | 145 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05135104 | Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period(PALBO) | unknown | — | 650 | Asociatia Oncohelp - Centrul de Oncologie OncohelpOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05861635 | The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression | unknown | Phase 4 | 42 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05388734 | Shared Decision Making on Care Pathways and CAMs: A Pilot Study | unknown | N/A | 100 | University Hospital, GrenobleOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT05857111 | Effectiveness Validation of CELBREA® in Symptomatic Women or With Diagnostic Doubt of Breast Pathology (DETECT-BH)(DETECT-BH) | unknown | — | 255 | Jose Ignacio SánchezOTHER | 1 | May 12, 2023 | clinicaltrials |
| NCT03484000 | The ONE-MIND Study: Evaluating the Efficacy of Online Mindfulness-Based Cancer Recovery During Chemotherapy Treatment | unknown | N/A | 178 | University of CalgaryOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05288686 | Use of Superparamagnetic Iron Oxide (SPIO) in Sentinel Lymph Node Detection for Breast Cancer | unknown | N/A | 282 | The University of Hong KongOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05574686 | Telemonitoring Hypertension and Breast Cancer | unknown | N/A | 40 | University of Mississippi Medical CenterOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT04877860 | Pain Treatment in a Breast Cancer Population. PaiNEd Study.(PaiNEd) | unknown | N/A | 72 | Universidad de GranadaOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05354882 | Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology(DEFACTO2) | unknown | N/A | 150 | Université Sorbonne Paris NordOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT04293276 | Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer(DAP-Her-01) | unknown | Phase 2 | 41 | Henan Cancer HospitalOTHER_GOV | 1 | May 6, 2023 | clinicaltrials |
| NCT05831553 | TIP in Patients Affected by Metastatic TNBC(TIP) | unknown | — | 100 | Fondazione per la Medicina PersonalizzataOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05842148 | Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)(IRONY) | unknown | — | 250 | Campus Bio-Medico UniversityOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05846997 | Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy(INTENT) | unknown | — | 40 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05836246 | The Development of Quantitative Ultrasound Imaging Software Platform | unknown | — | 196 | Seoul National University Bundang HospitalOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT05400954 | Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases(AREOLA-B) | unknown | — | 15,000 | The Netherlands Cancer InstituteOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05834686 | HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC | unknown | — | 50 | Beijing 302 HospitalOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05834699 | HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC | unknown | — | 50 | Beijing 302 HospitalOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05833802 | Computation Prediction of Drug Response Based on Omics Data | unknown | — | 25 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05833919 | Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients | unknown | Phase 2 | 122 | Consorzio OncotechOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05448963 | Pilot Study of Single-port Robot-assisted Nipple-sparing Mastectomy | unknown | N/A | 30 | Chang Gung Memorial HospitalOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05828238 | Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05170087 | Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies | unknown | — | 1,200 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT03578380 | Supermicrosurgery for Breast Cancer Survivors With Lymphedema. | unknown | N/A | 100 | Sykehuset TelemarkOTHER_GOV | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05036005 | Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)(NeoON) | unknown | Phase 4 | 108 | Institut fuer FrauengesundheitOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05177432 | Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer(QUEST) | unknown | Phase 1 | 26 | National University Hospital, SingaporeOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05258383 | Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy Tests(ELISA) | unknown | — | 320 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05814224 | Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA(MAGNETIC1) | unknown | N/A | 164 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT04733417 | A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer. | unknown | Phase 2 | 35 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05773391 | Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure) | unknown | N/A | 100 | Sun Yat-sen UniversityOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT04303741 | A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC | unknown | Phase 2 | 46 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 12, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Jun 2, 2023source: clinicaltrials